OBJECTIVE: To substantiate in a premenopausal population of women, the link between visceral adipose tissue and circulating plasminogen activator inhibitor 1 (PAI-1) levels. DESIGN: Study of correlations between anthropometric parameters and PAI-1 and evaluation of the changes induced by weight loss. SUBJECTS: Forty-two healthy pre-menopausal women (aged 18±51 y, with a wide range of body mass index (BMI, 21± 48.8 kg/m 2 ). Thirteen women were evaluated after weight loss (6.6 AE 3.3 kg). MEASUREMENTS: BMI, waist and hip circumferences. Total, subcutaneous and visceral adipose tissue areas at the L3±L4 level by computed tomography. Insulin, cholesterol, triglyceride, HDL cholesterol, PAI-1 activity, PAI-1 antigen and tissue plasminogen activator (tPA) antigen. RESULTS: PAI-1 activity, PAI antigen and tPA antigen were positively correlated with visceral adipose tissue, but not with subcutaneous adipose tissue. This correlation was independent of insulin or triglyceride levels. The amount of visceral adipose tissue explained 28% of the PAI-1 activity variance. Weight loss con®rmed this link, PAI-1 diminution being correlated only with visceral adipose tissue loss and not with total fat, insulin or triglyceride decrease. CONCLUSION: This study suggests, like in vitro studies, that visceral fat may be an important contributor to the circulating PAI-1.
Introduction
Clinical and experimental evidence strongly suggests that plasminogen activator inhibitor 1 (PAI-1) contributes to the pathogenesis of atherothrombosis.
1±4
On the other hand, it has long been known that ®brinolytic activity is decreased among obese subjects 5 and this phenomenon has been attributed to increased levels of PAI-1. 6±8 But until now, the direct cause of this increase in PAI-1 levels has remained largely unknown. PAI-1 levels are in close relation with body mass index (BMI), waist to hip ratio (WHR), plasma insulin and triglyceride levels. 9±15 It has been suggested that circulating insulin or triglyceride could regulate blood PAI-1 level and be responsible for the high PAI-1 levels observed in obese subjects. However, while PAI-1 synthesis is stimulated by insulin and very low density lipoprotein (VLDL) in hepatocytes and endothelial cells, respectively, 16±19 acute hyperinsulinemia does not increase PAI-1 levels in vivo 20, 21 and hypertriglyceridemia may coexist with normal PAI-1 levels. 22 In fact, these associations allow us to consider high plasma PAI-1 levels as a parameter of the insulin resistance syndrome 23 commonly observed among obese subjects, but do not show evidence of a causal relationship.
We and others have observed that PAI-1 levels were independently correlated with the WHR in various groups of subjects.
10±12 Recent in vitro arguments suggest that PAI-1 is produced by adipose tissue 24±26 and especially by visceral adipose tissue (VAT). 26, 27 Furthermore intervention studies have reported the bene®cial effect of weight loss on plasma PAI-1 activity in overweight individuals.
28±30
This work was intended to look at a relationship of PAI-1 levels with the amount of fat tissue, either visceral or subcutaneous, estimated by tomodensimetry in a group of premenopausal women with a wide range of body weight and to substantiate the association between VAT in PAI-1 levels, recently observed in Japanese subjects 27 and in men. 31 Additionally, to determine if the respective amounts of VAT and subcutaneous adipose tissue could be causally related to circulating PAI-1 levels, we compared the evolution of PAI-1 levels to that of fat tissue after a weight loss in a subgroup of these obese women.
Material and methods
Forty-two premenopausal women participated in the study after giving their informed consent. Their age ranged from 18±51 y, their BMI (kg/m 2 ) from 21± 48.8. None were diabetic, according to the WHO criteria, 32 and they did not take any oral contraceptive or medication known to in¯uence insulin sensitivity, such as biguanides, beta blockers or diuretics. Six were moderate smokers (1±10 cigarettesad).
Thirteen women (BMI ranging from 29.4±40.9) were submitted to a very low calorie diet (2500 kj (600 kcal)ad comprising 50% proteins) for four weeks, followed by a nutritionally balanced (5000 kj (1200 kcal)ad) diet for one week.
Weight and height were obtained at 08.00 h in underwear and without shoes. Waist circumference was measured at the level of the umbilicus and the hips, at the widest circumference at the great trochanters level.
Determination of abdominal adipose tissue (AT) distribution was performed by computed tomography (Elite Plus, Helscint, Haõ Èfa, Israe Èl). Total abdominal AT area (Tot AT), visceral AT area and subcutaneous AT (Sc AT) area were evaluated by ®ve consecutive slices 1 cm thick at the L3±L4 level.
CT scans were centered on the L3±L4, on a anteroposterior scout-view, with the patient in a supine position. The selected attenuation interval for AT determination was the most commonly used interval from 7190 Houns®eld Unit (HU) to 730 HU. 33 A cursor was used to de®ne the total abdominal AT area and the area of visceral fat (area inside the abdominal muscles). Manual correction for intestinal artefacts was performed.
Using 3D software, the ®ve slices were evaluated in order to obtain a 5 cm thick volume of total, visceral and subcutaneous AT that were then divided by 5 to obtain an area.
Blood samples were taken from an antecubital vein in resting subjects around 08.00 h and after a 12 h fast, during the follicular phase of the menstrual cycle.
For determination of ®brinolytic parameters, blood was collected on trisodium citrate (0.011 M ®nal concentration) in the presence of platelet inhibitor (Diatube, Diagnostica Stago, Asnie Áre-sur-Seine, France) and immediately cooled on ice. PAI-1 activity was determined using a commercially available kit obtained from Biopool (SpectrolyseaPL, Umea, Sweden). Enzyme linked immuno speci®c assays were used for PAI-1 Antigen (Ag) (Diagnostica Stago, France) and tPA Ag (Biopool, Umea, Sweden).
Blood collected on ethylene diamine tetracetic acid (EDTA) K3 (®nal concentration 0.34 M) was immediately centrifuged and the plasma frozen and stored for determination of insulin by radio-immuno-assay using a commercially available kit (CIS Bio Industries. Gif-Sur-Yvette, France). Plasma triglyceride and cholesterol were measured by standard methods.
Statistical analysis
Values are given as mean, standard deviation (s.d.) and range.
A correlation matrix was used to assess the relationship between parameters.
To evaluate the independent relationship of studied variables, a stepwise regression analysis was performed. The variable with the highest partial correlation coef®cient was entered at each step until no variable remained with an F value of 4. To compare the parameters before and after weight loss, a Wilcoxon paired test was used.
Results Table 1 shows the mean value, s.d. and range, for the various parameters which have been studied. The majority of the women were obese, but with a wide range of fat distribution, the mean WHR being 0.85 AE 0.08. Subcutaneous fat area was much larger than the visceral one, as expected in a group of female subjects. 34 High insulin levels facing normal blood glucose attested for insulin resistance. Mean PAI-1 activity and antigen levels were elevated, the normal range being (mean AE s.e.m.) 9.8 AE 1.2 Uaml and 10.9 AE 1.9 ngaml in a group of 20 control subjects (BMI`25). 35 The relationships between the various anthropometric parameters are presented in Table 2 . As expected, BMI and waist circumference were in close relation with the amount of total, visceral and subcutaneous fat. The WHR was mainly correlated with VAT and Tot AT. It must be observed that the correlation between the amounts of VAT and Sc AT was of borderline signi®cance. Among the anthropometric parameters, only WHR, waist circumference and VAT were positively associated with increasing age.
Plasma insulin was strongly related to all the anthropometric parameters while plasma triglyceride, total and HDL cholesterol were related to BMI, visceral and total fat (Table 3) . Table 3 shows that PAI-1 activity was signi®cantly related to visceral and total fat, but not to subcutaneous fat and, as expected, with plasma insulin and triglyceride. Interestingly, while PAI-1 levels were strongly associated with the visceral fat area, these levels appeared independent of age. After adjustment to visceral fat in a multiple stepwise regression analysis, the relationship with insulin and triglyceride disappeared. 28% of the PAI-1 activity variance was explained by visceral fat. PAI-1 activity, PAI-1 Ag and tPA were closely related all together (data not shown) and PAI Ag and tPA bore almost the same relationships as PAI-1 activity with the adipose tissue Visceral fat and PAI-1 level B Janand-Delenne et al as well as the biological parameters of the insulin resistance syndrome.
Effect of weight loss
Four weeks on a very low calorie diet, followed by a week on a 5000 kj (1200 kcal) nutritionally balanced diet induced a mean weight loss of 6.6 kg, a mean loss of 84 cm 2 of abdominal fat corresponding to 55 cm 2 of subcutaneous and 29 cm 2 of visceral, but individual variations were large (Table 4) . Visceral fat was decreased by 22.3% and subcutaneous by 14.4%. Apart from WHR, triglycerides and tPA antigen, a fall in all the parameters studied followed the loss of weight. No change in tPA Ag was observed after weight loss, this may be due to the fact that tPA levels are less sensitive to weight loss, 30 and especially when they are in the normal range. The absolute change in PAI-1 activity was compared to that of total, visceral and subcutaneous fat as well as that of plasma insulin and triglyceride levels ( Figure 1 and Figure 2 ). Figure  1 shows that the decrease of PAI-1 activity was signi®cantly proportional to that of visceral fat, but not to the other parameters.
Discussion
Increased plasma PAI-1 levels have been observed among obese subjects 9±12 and this impairment in ®brinolytic activity has been included as a new component enriching the plurimetabolic syndrome (or syndrome X or insulin resistance syndrome). 36 However, little is known about the mechanisms linking high PAI-1 levels to the other components of this syndrome and the cause of its excessive production is still a matter of debate. In this series, we con®rm the close relation of PAI-1 levels to the various parameters of the insulin resistance syndrome, but the strongest correlation coef®cient was that of visceral fat area. This association appeared independent, the other ones disappearing after adjustment to visceral fat. These results obtained in premenopausal women extend that of two other recent cross sectional studies conducted on men 31 and on Japanese subjects. 27 However, this association does not imply that a causal relationship could exist. It has been abundantly demonstrated that weight loss is followed by an improvement in ®brinolytic activity and a decrease in PAI-1 levels.
28±30 However the change in PAI-1 level has not been speci®cally related to any of the various modi®cations induced by a weight loss. In our series, PAI-1 levels decreased as expected, but it is important to note that the variation of PAI-1 levels was proportional to visceral fat on an individual basis, and not to that of subcutaneous fat or plasma insulin or triglyceride levels. These longitudinal data represent a strong argument for an independent link between visceral fat and PAI-1 levels.
The close association and parallel evolution after weight loss of visceral fat and PAI-1 levels suggest that visceral fat tissue may be an important source of the circulating PAI-1. This suggestion is strongly supported by the recent demonstration 26 that human fat tissue can express PAI-1 mRNA and increase PAI-1 antigen in the conditioned medium and that omental tissue explant produces signi®cantly more PAI-1 antigen than did subcutaneous tissue from the same individual.
It is well known that weight loss induced by an hypocaloric diet improves the various cardiovascular risk factors associated with insulin resistance and among them PAI-1 levels. 28±30 The results presented here as well as those on human fat tissue in vitro 26 allow us to suggest that the loss of visceral fat is the cause of the decrease in PAI levels and of the improvement in ®brinolytic activity. This point Figure 1 Relation between absolute changes after weight loss in plasminogen activator inhibitor 1 (PAI-1) activity and visceral adipose tissue (VAT) (upper panel), Sc AT (middle panel) and Tot AT (lower panel).
Visceral fat and PAI-1 level B Janand-Delenne et al would suggest that therapeutic manoeuvres aimed at reducing, more or less speci®cally, visceral fat in obese subjects would be bene®cial to prevent cardiovascular disease.
